PDAC

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

PDAC
Nov 10, 2024, 02:00 | Insight
Nelson Dusetti: The applicability of our signatures in predicting treatment sensitivity and resistance in PDAC patients
Nelson Dusetti, Scientific Director of the company Predicting Med(CSO) and Chair of TRANSLATE-IT CRCM, shared an…
Oct 11, 2024, 13:53 | Blog,Opinion
WRAD complex's impact on epigenetic regulation and immunoediting in PDAC by Francesca Citron
Wafik S. El-Deiry shared a post on X: '' Francesca Citron from MD Anderson Cancer…
Oct 6, 2024, 17:09 | Insight
A common mutation in the KRAS gene is associated with OS in PDAC - Weill Cornell Medicine
Weill Cornell Medicine shared a post on X: "A common mutation in the KRAS gene…
Sep 13, 2024, 15:01 | Insight
Piotr Wysocki: IPMN-derived pancreatic cancer patients benefit from adjuvant chemotherapy only with nodal involvement and elevated preoperative CA19-9
Piotr Wysocki recently shared a post on LinkedIn: "A recent international multicenter study published in…
Jul 19, 2024, 22:56 | Insight
Stunning interim clinical trial data from Revolution Medicines
Grainne O'Kane, Medical Oncologist at Princess Margaret Cancer Centre, shared a post by Kenneth Olive,…
Jul 10, 2024, 12:12 | Insight
Piotr Wysocki: Active surveillance in patients at high risk of pancreatic cancer may significantly improve their outcomes
Piotr Wysocki recently posted on LinkedIn: "Blackford AL et al. published results of a cohort study…
Jun 27, 2024, 14:31 | Societies
Keep up with ESMOGI24 with Teresa Macarulla
ESMO GI 2024 is taking place as an onsite event in Munich, Germany, from 26 to 29…
Jun 26, 2024, 12:40 | Societies
EGFR co-inhibition in KRAS
Megan Barnet, Medical Oncologist at The Kinghorn Cancer Centre, shared on X: "Great summary from…
Jun 26, 2024, 08:00 | Insight
New Paper Alert! Perioperative Modified FOLFIRINOX Improves Survival in Resectable Pancreatic Cancer: Results from a Phase 2 Trial
Perioperative Modified FOLFIRINOX Improves Survival in Resectable Pancreatic Cancer: Results from a Phase 2 Trial…
Jun 24, 2024, 15:49 | Insight
Tanja Obradovic: The landscape of targeting KRAS mutations just got busier
Tanja Obradovic shared on LinkedIn:          . "The landscape of KRAS mutations…
Jun 8, 2024, 09:58 | Insight
Angelo Pirozzi: Circulating immune-related proteins might predict the efficacy of Immune Checkpoint Inhibitors
Angelo Pirozzi, Research Fellow at Mayo Clinic, shared on X:          .…
Jun 2, 2024, 22:12 | Blog
Jacquelyne Gaddy non-genomic factors are likely the cause of outcome disparities in PDAC - Yale Cancer Center
Yale Cancer Center shared on X/Twitter: "Jacquelyne Gaddy presents research showing non-genomic factors are likely the…
May 28, 2024, 08:56 | Blog
Angelo Pirozzi: CAR-T cells targeting claudin18.2 in pretreated advanced PDAC by Changsong Qi et al.
Angelo Pirozzi, Medical Oncology Fellow at Humanitas University and Research Fellow at Mayo Clinic (Phoenix),…
Apr 19, 2024, 16:30 | Insight
New Paper Alert! Outcomes of high-risk individuals undergoing pancreatic cancer surveillance
Effective Surveillance Strategies for High-Risk Pancreatic Cancer Individuals Authors: Aleksander M. Bogdanski, Jeanin E. van…
All: 14 Posts: 1 - 100
Special Coverage